<DOC>
	<DOCNO>NCT02300987</DOCNO>
	<brief_summary>To assess efficacy LEE011 compare placebo patient relapsed/refractory teratoma recent progression</brief_summary>
	<brief_title>A Randomized , Blinded , Placebo-controlled , Phase II Trial LEE011 Patients With Relapsed , Refractory , Incurable Teratoma With Recent Progression</brief_title>
	<detailed_description />
	<mesh_term>Teratoma</mesh_term>
	<criteria>Diagnosis teratoma additional standard surgical medical therapy exist Patients must complete least 1 prior line chemotherapy germ cell tumor ( except patient present primary pure teratoma need receive previous chemotherapy ) Radiographic progression , define RECIST v.1.1 , last cancer treatment within 12 week prior enrollment , compare scan within 1 year enrollment . Availability archival newly obtain tumor sample ( collected diagnosis progression ) accompany pathology report Meaurable evaluable extracranial disease define RECIST v 1.1 Malignant germ cell tumor mixed histology embryonal carcinoma , choriocarcinoma , yolk sac tumor seminoma . Note refers histology time enrollment , histolgy time initial presentation . Pathologic evidence malignant transformation CNS disease unless radiation therapy and/or surgery complete serial evaluation demonstrate stable disease Prior treatment CDK4/6 inhibitor therapy Systemic antineoplastic therapy experimental therapy within 3 week first dose study drug ( 6 week prior nitrosoureas , bevacizumab , mitomycin C ) Major surgery ≤ 2 week radiotherapy ≤ 4 week prior plan start study drug patient recover major side effect . Requirement treatment prohibit medication include strong CYP3A inhibitor , strong CYP3A inducer , CYP3A substrates narrow therapeutic index , medication strong risk QT prolongation Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Teratoma ,</keyword>
	<keyword>Germ Cell tumor ,</keyword>
	<keyword>incurable teratoma ,</keyword>
	<keyword>CDK4/6 ,</keyword>
	<keyword>LEE011</keyword>
</DOC>